CGX, a standardized herbal syrup, inhibits colon-liver metastasis by regulating the hepatic microenvironments in a splenic injection mouse model

Background: Colon-liver metastasis is observed in approximately 50% of patients with colorectal cancer and is a critical risk factor for a low survival rate. Several clinical studies have reported that colon-liver metastasis is accelerated by pathological hepatic microenvironments such as hepatic st...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sung-Bae, Hwang, Seung-Ju, Son, Chang-Gue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465806/
https://www.ncbi.nlm.nih.gov/pubmed/36105183
http://dx.doi.org/10.3389/fphar.2022.906752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465806/
https://www.ncbi.nlm.nih.gov/pubmed/36105183
http://dx.doi.org/10.3389/fphar.2022.906752

Ejemplares similares